CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +16,333 | 595,829 | ||
| 2023-02-28 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −7,718 | $2.03 | $16K | 588,111 |
| 2023-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −16,333 | 0 | ||
| 2023-02-21 | Berg Aaron EVP, President US | Grant or award | +58,267 | 530,307 | ||
| 2023-02-21 | Berg Aaron EVP, President US | Shares withheld for taxes | −28,162 | $1.80 | $51K | 502,145 |
| 2023-02-21 | Berg Aaron EVP, President US | Grant or award · Stock Option (Right to Buy) | +269,600 | 269,600 | ||
| 2023-02-21 | Berg Aaron EVP, President US | Grant or award · Restricted Stock Units | +134,800 | 134,800 | ||
| 2023-02-21 | Berg Aaron EVP, President US | Grant or award · Restricted Stock Units | +29,133 | 29,133 | ||
| 2023-02-21 | Reilly Thomas Charles SVP and CFO | Grant or award · Stock Option (Right to Buy) | +269,600 | 269,600 | ||
| 2023-02-21 | Reilly Thomas Charles SVP and CFO | Grant or award · Restricted Stock Units | +134,800 | 134,800 | ||
| 2023-02-21 | Reilly Thomas Charles SVP and CFO | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2023-02-21 | Mikhail Karim President and CEO | Grant or award | +33,334 | 293,508 | ||
| 2023-02-21 | Mikhail Karim President and CEO | Shares withheld for taxes | −10,001 | $1.80 | $18K | 283,507 |
| 2023-02-21 | Mikhail Karim President and CEO | Grant or award · Stock Option (Right to Buy) | +1,601,500 | 1,601,500 | ||
| 2023-02-21 | Mikhail Karim President and CEO | Grant or award · Restricted Stock Units | +800,800 | 800,800 | ||
| 2023-02-21 | Mikhail Karim President and CEO | Grant or award · Restricted Stock Units | +66,666 | 66,666 | ||
| 2023-02-21 | Ketchum Steven B Chief Scientific Officer | Grant or award | −29,134 | 594,016 | ||
| 2023-02-21 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −14,520 | $1.80 | $26K | 579,496 |
| 2023-02-21 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +269,600 | 269,600 | ||
| 2023-02-21 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +134,800 | 134,800 |
Page 16 of 67 · 1,339 trades